Policy Featured Pharmaceuticals

CDSCO Signals Shift Towards Smarter, Risk-Based Pharma Regulation

Regulators and industry leaders at iPHEX 2026 emphasised the need for risk-based and proportionate enforcement, simpler compliance processes and clearer distinction between procedural lapses and serious regulatory violations.